Science in Seconds | A New Path Toward Life Without Daily HIV Pills
Scientists at Gladstone Institutes figured out why some people naturally control HIV even after stopping therapy—and how we can leverage that to treat others.
People living with HIV need to follow a daily regimen of medications (known as antiretroviral therapy) for the rest of their lives. If they stop, the virus usually rushes back within weeks. But a few rare individuals keep the virus under control for months, or even years, after stopping antiretroviral therapy.
Nadia Roan and her team set out to understand why this happens by examining blood samples from people with HIV who participated in clinical trials, during which they deliberately stopped therapy.
In this video, Nadia Roan and Ashley George explain how they uncovered a new path toward long-term health without the need for daily HIV pills.
Their new study, published in Immunity, shows that metformin, a common diabetes drug, might be able to delay—or even prevent—HIV rebound. The scientists are now working to advance their findings into clinical trials that test whether metformin can help suppress HIV.
Up Next
Gladstone Scientists Are Awarded $2 Million to Map How HIV Affects the Immune System
By uniting the power of single-cell sequencing, organoids, and artificial intelligence, scientists are entering a new era of HIV research.
Scientists Map How HIV Hijacks Human Cells—and How Cells Can Fight Back
A new genetic roadmap reveals hundreds of hidden players in HIV infection, including two proteins that stop HIV in its tracks.
Why Some People Naturally Control HIV Even After Stopping Therapy—and How We Can Leverage That to Treat Others
New research offers a path toward life without daily HIV pills, suggesting common diabetes pill could help achieve long-term remission.
New Tool Reveals the Secrets of HIV-Infected Cells
Developed by Gladstone scientists, HIV-seq could uncover new opportunities for treating HIV.
Get Involved
Join the Team
Our people are our most important asset. We offer a wide array of career opportunities both in our administrative offices and in our labs.
Open PositionsPartner With Us
Discoveries don’t stay in our labs. Gladstone facilitates spinout companies to advance promising therapies, shortening the path between scientific discovery and helping real patients.
Learn MoreGive
Your gift to Gladstone will allow our researchers to pursue high-quality science, focus on disease, and train the next generation of scientific thought leaders.
Donate Now